Efficacy and Safety of Erenumab for Erythema and Flushing in Rosacea

This nonrandomized controlled trial analyzes the efficacy and safety of erenumab, an anti –calcitonin gene-related peptide receptor monoclonal antibody, for rosacea-associated erythema and flushing.

Source: JAMA Dermatology - April 17, 2024 Category: Dermatology Source Type: research